BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Atrial fibrillation clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for atrial fibrillation: 160 (67 sponsors; 28 newly posted in the last 180 days, 6 stopped in the last 180 days; 9 new-entrant sponsors). Momentum score 9.1, rank 77 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 0, Phase 1 1, Phase 2 11, Phase 3 5, Phase 4 1, N/A 142.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Regeneron Pharmaceuticals REGN3P3 2, P2 111
Anthos Therapeutics, Inc.2P2 1, P3 100
Novartis Pharmaceuticals NVS2P3 1, P2 110
Janssen Research & Development, LLC1P3 101
Boston Scientific Corporation BSX20NA 2025
Medtronic Cardiac Ablation Solutions MDT11NA 1112
Biosense Webster, Inc.10NA 1024
Abbott Medical Devices9NA 902
Shanghai MicroPort EP MedTech Co., Ltd.6NA 610
Asklepios proresearch5NA 511
Kardium Inc.5NA 521
LUMA Vision Ltd.5NA 512
Volta Medical5NA 521
AtriCure, Inc. ATRC4NA 402
CardioFocus4NA 411
Pulse Biosciences, Inc. PLSE4NA 402
CathVision ApS3NA 302
Hangzhou Dinova EP Technology Co., Ltd3NA 300
HUINNO Co., Ltd3NA 322
Append Medical Ltd.2NA 210
Biotronik SE & Co. KG2NA 200
Conformal Medical, Inc2NA 200
Javelin Medical2NA 200
Lifetech Scientific (Shenzhen) Co., Ltd.2NA 200
Peerbridge Health, Inc2NA 210

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12-08 est.P3Janssen Research & Development, LLCNCT05757869 A Study of Milvexian Versus Apixaban in Participants With Atrial FibrillationAtrial Fibrillationactive not recruiting20284
2027-02-09 est.P2Regeneron Pharmaceuticals REGNNCT07175428 Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationAtrial Fibrillation (AF)recruiting1200

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
None found.

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "atrial fibrillation"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.